"We believe that the combination of Biomatrix's product development expertise and Genzyme's commercialization infrastructure will build significant value more rapidly than each enterprise could achieve on its own, " said Duke Collier, president of Genzyme Surgical Products, in a statement.

FORBES: Biotech Briefing: Genzyme Buys Biomatrix